IDIBAPS Scientific Core Facilities held on November 6th a seminar to inform users of the new opportunities they offer, and make a reminder of previou1
Dr. Josep Dalmau leads the IDIBAPS group Pathogenesis of autoimmune neuronal disorders, where he studies a group of disorders at the intersection of1
The TV3 Telethon Foundation held this evening a ceremony at the Barcelona Biomedical Research Park, where they presented the projects selected to be1
For the first time, scientists have used new technology which analyses the whole genome to find the cause of a genetic disease in what has previously1
The International Society for Bipolar Disorders (ISBD) recently presented an international consensus on the use of antidepressants in bipolar disorde1
Casal Infantil Urgell, a space for children's entertainment within the Centre Cívic Urgell in the Eixample district, organizes a family and solidarit1
ZEB proteins have recently acquired great relevance in molecular oncology because of their ability to regulate invasive and metastatic carcinomas thr1
The Myelin Repair Foundation and Bionure have entered a collaborative partnership agreement to advance therapeutics development for Multiple Sclerosi1
The Catalan biotech company AB-Biotics has acquired the rights to a patent of a technology developed by Universitat de Barcelona (UB), IDIBAPS, Hosp1
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular alterati1
